ReguPrep Free preview

Official sources are linked where cited · Preliminary guidance; no qualified legal or regulatory review. Editorial method and review status

COSMETIC ARTWORK REVIEW

Common cosmetic labeling mistakes to catch before printing

Most avoidable errors begin when teams review isolated text instead of the finished product, complete package, actual claims, and versioned formula together.

Check a cosmetic label

Three fictional errors and the correction record

Draft errorWhy it needs reviewCorrection task, not automatic approval
Draft: 50 mL only on a curved edgeNo documented unit, PDP or type-height review.Establish product form and physical panel before selecting the declaration and printed size.
Citric Acid 0.5% before Water 88%The low-concentration flexibility was applied to the whole list.Keep the above-1% order first; then apply the separate low-level/color rules.
Cosmetic serum: treats eczemaCalling it a cosmetic does not cancel the intended-use message.Hold the claim and review classification and evidence; do not copy an approved-sounding substitute.

These are constructed teaching examples, not customer cases or approved replacement labels. Preserve the rejected version, supporting source and exact revised artifact.

Eight recurring problems

  1. Classification is assumed: a cream, serum, or shampoo is called a cosmetic without reviewing therapeutic, structure/function, or disease claims that may signal drug intended use.
  2. The identity statement is vague: branding and benefit language displace the common or usual description of what the product is.
  3. Quantity is copied from another market: units, location, package display area, and prominence are not checked on the final U.S. artwork.
  4. The ingredient list is built from a supplier sheet: the team does not reconcile the finished formula, sub-ingredients, colors, fragrance components, or declaration order.
  5. Company information lacks an evidence trail: a business name appears, but its label role, place of business, and responsible-person records are unclear.
  6. Warnings are treated as boilerplate: restricted ingredients, professional use, aerosols, eye-area products, user groups, and foreseeable misuse are not considered.
  7. Claims are reviewed one line at a time: product names, images, before-and-after material, testimonials, directions, websites, and marketplace copy are omitted.
  8. Old artwork survives a formula change: the approved proof is not tied to the formula, package, review date, source version, and open issues.

A stronger release sequence

Freeze the formula, intended use, package configuration, and all claim-bearing material. Compare the final-size proof with every panel and the actual container. Resolve classification first, then identity and quantity, ingredient declaration, business details, warnings, directions, and claims. Keep a visible review queue for unreadable or contradictory evidence and rerun the check after any material change.

Official starting points

Fix the underlying issue

Editorial examples updated . Source-version limits remain unchanged; qualified professional review pending.